Back
Avance Gas Holding Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
54
AVACF
Avance Gas Holding
Last Price:
10.13
Seasonality Move:
15.96%
Sell
49
RARE
Ultragenyx Pharmaceutical
Last Price:
58.74
Seasonality Move:
-0.7%
Buy
54
Avance Gas Holding (AVACF)
is a Buy
Is Avance Gas Holding a Buy, Sell or Hold?
- The current Avance Gas Holding [AVACF] share price is $10.42. The Score for AVACF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- AVACF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.77. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AVACF Stock Price Chart
What is Avance Gas Holding's stock price today?
-
The Avance Gas Holding share price today is $10.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVACF is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
AVACF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 34.14 | Sell |
| Chaikin Money Flow: | 15602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.23 - 12.73) | Sell |
| Bollinger Bands (100): | (12.41 - 16.99) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | -154927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.53 - 58.27) | Buy |
| Bollinger Bands (100): | (39.73 - 52.87) | Buy |
AVACF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10 | Buy |
| 20-day SMA: | 11.06 | Sell |
| 50-day SMA: | 13.11 | Sell |
| 200-day SMA: | 13.74 | Sell |
| 8-day EMA: | 10.35 | Buy |
| 20-day EMA: | 11.14 | Sell |
| 50-day EMA: | 12.64 | Sell |
| 200-day EMA: | 13.23 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.87 | Buy |
| 20-day SMA: | 57.08 | Buy |
| 50-day SMA: | 51.49 | Buy |
| 200-day SMA: | 46.42 | Buy |
| 8-day EMA: | 57.94 | Buy |
| 20-day EMA: | 56.47 | Buy |
| 50-day EMA: | 52.53 | Buy |
| 200-day EMA: | 46.74 | Buy |
Avance Gas Holding Earnings Growth & AVACF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Avance Gas Holding Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||